- THB
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
5.42%
Fundamental score
-

Is SANOFI80.BK undervalued?

Graham number

The Graham number of Sanofi cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sanofi fundamental analysis

No fundamental analysis for Sanofi yet.

Sanofi stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in Finland and Germany. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu…

Full company profile